SCHEMBL5311146

SCHEMBL5311146

CN1CCN(c2cccc3c2OC(C(=O)Nc2ccc(N4CCOCC4)cc2)CC3F)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 3/20 0.56
▸ KCNH2 Q12809 1/20 0.56
▸ RAD52 P43351 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ MAPT P10636 4/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14263999 0.82 HTR1B (0.73) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL5354642 0.82 HTR1B (0.73) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL14370170 0.82 HTR1B (0.73) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL14370221 0.81 HTR1B (0.57) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL14264000 0.81 HTR1B (0.57) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL5308451 0.74 HTR1B (0.78) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL4806699 0.74 ALDH1A1 (0.54) HTR1BKCNH2RAD52L3MBTL1ALDH1A1
SCHEMBL5308358 0.73 HTR1B (0.79) HTR1BKCNH2RAD52ALDH1A1NPC1
SCHEMBL22411172 0.73 HTR1B (0.57) HTR1BKCNH2L3MBTL1ALDH1A1MAPT
SCHEMBL4247675 0.71 HTR1B (1.00) HTR1BKCNH2RAD52ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO disclosed
Send feedback